Positive End-expiratory Pressure (PEEP) in Predicting Fluid Responsiveness in Patients Undergoing One-lung Ventilation
NCT ID: NCT03794414
Last Updated: 2020-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2019-01-31
2020-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Positive End-Expiratory Pressure on Biventricular Function During One-Lung Ventilation
NCT02483806
Optimal Level of PEEP in Protective One-lung Ventilation
NCT03856918
Positive End-expiratory Pressure and Alveolar Recruitment for One Lung Ventilation
NCT01652612
The Effect of Positive End-Expiratory Pressure on Functional Residual Capacity During Mechanical Ventilation
NCT03511651
Effects of Different I:E Ratio on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus Position
NCT01499212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators hypothesized that applying PEEP in one-lung ventilating patients can also change dynamic parameters and the magnitude of the change of stroke volume variation, pulse pressure variation can predict fluid responsiveness. The investigator applied PEEP 10 mmHg in one-lung ventilating patients and observed the dynamic parameters including stroke volume variation, pulse pressure variation and then infused 6ml/kg of crystalloid for fluid challenge and diagnosed fluid responsiveness as 10% increase of stroke volume after fluid challenge.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fluid responder
patients with 10% or more increase in stroke volume after fluid challenge. Both arms receive PEEP challenge.
PEEP challenge
apply PEEP 10 mmHg in one-lung ventilating patients.
fluid non-responder
patients with no increase or less than 10% increase in stroke volume after fluid challenge. Both arms receive PEEP challenge
PEEP challenge
apply PEEP 10 mmHg in one-lung ventilating patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEEP challenge
apply PEEP 10 mmHg in one-lung ventilating patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* moderate to severe valvular heart disease moderate to severe pericardial effusion left ventricular ejection fraction \< 40%
* moderate to severe chronic obstructive lung disease
* unable to insert oesophageal Doppler Monitor (ODM) probe ( esophageal stent, esophageal cancer, previous esophageal surgery, esophageal stricture, esophageal varices, pharyngeal pouch and severe coagulopathy )
* patient refusal
* cannot understand the protocol
* less than 50kg or over 100kg in weight
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hallym University Kangnam Sacred Heart Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Choi Eun MI
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eun-mi Choi, Professor
Role: STUDY_CHAIR
Kangnam Sungshim Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangnam Sungshim Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-11-028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.